Brind.

The SEC declared the shelf registration statement effective for Alaunos Therapeutics on June 23, 2025.

2 reports, 1 independent Updated Aug 14

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The SEC declared the shelf registration statement effective for Alaunos Therapeutics on June 23, 2025.

Who's involved

What this event is mainly about

Alaunos Therapeutics SEC

Keep exploring

The entities involved

Alaunos Therapeutics
immuno-oncology company

Nothing else this week.
SEC
Slovak company
- DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
- The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Coverage

Newest first; wire copies grouped

Aug 14tickerreport.com
Jun 23Unknown outlet